Virtus Health

Name

Virtus Health

Legal name

Virtus Health Pty Ltd

Website

https://virtushealth.com.au

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

1,001–5,000 employees

Ownership category

akta.pro rank

Product category

Assisted Reproductive Services

NAICS

Family Planning Centers (62141)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Reproductive Endocrinology & Infertility (IVF/Fertility) (HLAKAJAC)

akta.pro secondary industries

Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD), Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ)

Keywords

• Assisted reproductive services
• Fertility treatment services
• Reproductive genetics testing
• Preimplantation genetic testing
• Specialist day hospital services

Headquarters

HQ city

Greenwich

HQ country

Australia

HQ region

Oceania

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Fertility and IVF Treatment Services: Virtus Health generates revenue primarily through providing assisted reproductive services including IVF, ICSI, egg freezing, embryo freezing, and related fertility treatments at its clinic network. Revenue is generated from patient treatment cycles, consultations, and procedures.
2. Day Hospital Surgical Services: Revenue from operating seven specialist day hospitals across Australia supporting fertility services and other operating specialists across multiple surgical disciplines.
3. Diagnostics and Pathology Services: Virtus Diagnostics provides comprehensive reproductive pathology and genetics services including genetic carrier screening, fertility blood tests, Non-Invasive Prenatal Testing (NIPT), and andrology services.
4. Reproductive Genetics: Virtus Genetics provides preimplantation genetic testing, karyomapping, and reproductive genetics services.

Go-to-market motion2 records

Distribution channels14 records

Marketing channels6 records

Core offering

Virtus Health operates a global network of fertility clinics providing assisted reproductive services including IVF, ICSI, egg freezing, embryo freezing, donor egg IVF, and fertility preservation, supported by comprehensive reproductive diagnostics and pathology, reproductive genetics services (PGT, karyomapping, NIPT), and seven specialist day hospitals across Australia. The company also deploys proprietary AI technology including the Ivy AI embryo selection system and AI sperm detection algorithms, and conducts translational research in antioxidant embryo culture media and whole-genome sequencing for personalized IVF dosing.

Product overview

Virtus Health is a global leader in assisted reproductive services operating as a unified portfolio of fertility clinic brands, diagnostic laboratories, and specialist day hospitals. The organization offers a comprehensive spectrum from affordable IVF (The Fertility Centre, Egg Freezing Australia) to full-service fertility treatment (IVFAustralia, Melbourne IVF, Queensland Fertility Group, TasIVF, Sims IVF, Aagaard, Trianglen, Complete Fertility, Virtus Fertility Centre Singapore) alongside specialist day hospitals, Virtus Diagnostics (NATA/RCPA/ISO accredited reproductive pathology), and Virtus Genetics. The company's technology portfolio includes the proprietary Ivy AI embryo selection system (commercially available since 2019), AI sperm detection algorithms, and a genomic sequencing initiative. Clinical research capabilities span antioxidant embryo culture media, whole-genome sequencing for IVF medication personalization, and a global RCT for AI embryo evaluation. The company helps more than 5,000 people per year become parents through 43 fertility clinics, 63 laboratories, and 7 day hospitals across 5 countries.

Differentiator

Problem solved

Functional benefit

Brands

• Ivy Artificial Intelligence: AI-powered embryo selection technology developed in partnership with Harrison.ai and Vitrolife for improved embryo evaluation and selection in IVF treatments
• Precision Fertility Digital Platform
• Virtus Ventures

Products and services

• Fertility and IVF Treatment Services Comprehensive assisted reproductive services including IVF, ICSI, egg freezing, embryo freezing, donor egg IVF, fertility preservation, and reproductive genetics, delivered through a portfolio of fertility clinic brands (IVFAustralia, Melbourne IVF, Queensland Fertility Group, TasIVF, Sims IVF, Aagaard Fertility Clinic, Trianglen Fertility Clinic, Complete Fertility Centre, and Virtus Fertility Centre Singapore) for individuals and couples experiencing infertility.
• The Fertility Centre (Affordable IVF) Affordable IVF treatment through a simplified and standardized treatment model at locations in Brisbane, Melbourne, Liverpool, Wollongong and Gold Coast. For patients seeking quality IVF treatment at significantly lower cost than full-service fertility clinics.
• Egg Freezing Australia Specialized elective egg freezing services for women seeking to preserve fertility for future use, using vitrification method with 92% egg freezing survival rate and fertilisation rate of approximately 65% for frozen/thawed eggs similar to fresh eggs.
• Virtus Specialist Day Hospitals Seven specialist day hospitals across Australia (Alexandria, City West, North Shore, Mackay, Spring Hill, Hobart, and Melbourne IVF Procedure Centre) supporting fertility services and operating specialists in gynaecology, gastroenterology, colorectal surgery, urology, plastic surgery, ophthalmology, dental surgery, and hand surgery.
• Virtus Diagnostics Comprehensive reproductive pathology and genetics laboratory service offering genetic carrier screening, fertility blood tests (AMH, NK assay), Non-Invasive Prenatal Testing (NIPT via Panorama Screen), and advanced andrology services (SCSA, sperm DNA fragmentation, digital high magnification imaging, cryopreservation). NATA, RCPA & ISO accredited laboratories.
• Virtus Genetics Reproductive genetics service focused on genetic screening and testing, including Preimplantation Genetic Testing (PGT), karyomapping for single-gene disorders, and genetic counseling to help patients understand hereditary conditions before and during fertility treatment.

Quantifiable outcome

• Egg freezing survival rate of 92% using vitrification method
• +4 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature8 records

Partnerships

13 partnerships are on record, tiered core and minor.

• Australian Netball Players' Association (ANPA)coreGTM or Marketing Partner · 1 December 2025Partnership providing elite netball athletes with free fertility health checks including pelvic ultrasound and AMH blood tests. First fertility care partnership of its kind in elite women's netball. Includes workshops, webinars, podcasts and education.
• 23StrandscoreStrategic or Co-development Partner · 1 March 2024Virtus Health invested in 23Strands, an early-stage genomics business utilizing whole genome sequencing and AI to provide better patient outcomes in IVF. Part of Virtus Ventures portfolio. 23Strands brings innovation combining data from scientific research, medical records and genetics.
• NeoGenix BiosciencescoreStrategic or Co-development Partner · 1 March 2024Virtus Health invested in NeoGenix Biosciences, a med-tech startup commercializing IVF medical devices leveraging microfluidics. AI-based sperm selection, gamete handling, gamete detection, and fertilisation platforms. Received several hundreds of thousands in in-kind commercialisation support.
• Monash UniversitycoreStrategic or Co-development Partner · 1 November 2023World-first study partnership with 23Strands and Monash University studying how whole genome sequencing can achieve better patient outcomes with IVF medications. Received $3 million federal government grant from MRFF. Research aims to create AI-driven tool for personally targeted dosing.
• UNSW FounderscoreStrategic or Co-development Partner · 1 April 2023Virtus Health and UNSW Founders partnered to launch a dedicated Women's Health stream of the Health 10x Accelerator program. First initiative of Virtus Ventures. Aims to equip startups with business expertise and resources for health technology ecosystem understanding and commercialization.
• The George Institute for Global HealthcoreStrategic or Co-development Partner · 1 April 2023Co-created Health 10x Accelerator program focused on women's health innovation, created by UNSW Founders and The George Institute for Global Health.
• Ronde MediacoreGTM or Marketing Partner · 1 February 2023Virtus Health opened clinic doors to Ronde Media for production of 'Big Miracles' docu-series on Channel 9. The series follows real patients through IVF journeys, filmed exclusively in Virtus clinics. Multiple seasons produced.
• University of MelbournecoreStrategic or Co-development Partner · 1 January 2023Research collaboration for antioxidant embryo culture media development. Professor David Gardner conducted lab research at University of Melbourne leading to clinical trials.
• University of Technology Sydney (UTS)minorStrategic or Co-development Partner · 1 January 2023AI sperm selection research collaboration with UTS Warkiani Lab. Study carried out at IVFAustralia and in the Warkiani Lab, UTS.
• Drop BiominorStrategic or Co-development Partner · 1 May 2021Collaboration with Drop Bio aiming to track and explain the critical role that chronic inflammation plays in the success of ARS. Drop Bio is an Australian biotechnology and digital health company.
• CooperSurgicalcoreTechnology or Integration · 1 February 2021Collaboration announced with CooperSurgical, a leading international provider of fertility and genomic solutions, for advancing reproductive technology capabilities.
• VitrolifecoreTechnology or Integration · 1 April 2019Transfer and collaboration agreements with Vitrolife for Ivy AI system development. The Ivy AI technology for embryo evaluation was developed in partnership with Harrison.ai and Vitrolife.
• Harrison.aicoreTechnology or Integration · 1 April 2019Development partner for Ivy AI system - artificial intelligence for embryo evaluation. Harrison.ai developed the AI algorithm for comprehensive embryo assessment.

Scale indicators9 records

Recent moves10 records

Expansion highlights6 records

Others

• Vitrolife: Swedish-listed developer of IVF media, time-lapse incubators, and lab equipment, and a co-development partner for Virtus's Ivy AI. Comparable as the leading upstream technology partner in the ART lab, supplying EmbryoScope+ and culture media to the broader industry.

Direct peers

• Monash IVF Group: Australia's largest dedicated fertility clinic network, also ASX-listed until recently. Direct competitor to Virtus's IVFAustralia, Melbourne IVF, and Queensland Fertility Group across the Australian market with overlapping service lines in IVF, ICSI, and PGT.
• Care Fertility: UK fertility clinic network offering IVF, ICSI, PGT, and egg/sperm donation. Comparable in size and product range to Virtus's Complete Fertility Centre in the UK south coast and a meaningful regional competitor in the British market.
• Genea: Sydney-headquartered fertility clinic group (formerly Sydney IVF) operating across Australia. Direct competitor in IVF and reproductive genetics, with comparable investments in time-lapse embryo culture and AI-based embryo assessment.
• Bourn Hall Clinic: UK fertility clinic network founded by the original IVF pioneers. Direct UK competitor to Virtus's Complete Fertility Centre with overlapping NHS and private service offerings and similar focus on clinical success rates.
• IVI-RMA Global: World's largest assisted reproduction group (KKR-backed) operating across Europe, Latin America, and now the US. Directly comparable to Virtus as a multi-country fertility clinic platform with significant investment in reproductive genetics and laboratory technology.
• The Fertility Partnership: European fertility clinic network operating in the UK, Ireland, Spain, and the Nordics. Direct competitor to Virtus's Sims IVF in Ireland and to its UK and Danish clinics, with similar tiered premium and value sub-brands.
• TFP Fertility: Pan-European fertility clinic group (UK, Poland, Netherlands, Czech Republic, Germany). Highly comparable to Virtus as a multi-country ART roll-up with day hospital and diagnostics adjacencies.

Broad incumbents

• CooperSurgical: US-headquartered leader in fertility and genomic solutions, partnered with Virtus since 2021. Not a direct clinic competitor but the dominant supplier of ART consumables, devices, and PGT services globally; comparable as a broad incumbent in the fertility value chain.

Regional players

• Prelude Network (Inception Fertility): Largest US fertility clinic network (a subsidiary of Inception Fertility). Not a direct competitor given Virtus's US exclusion, but the closest US analog in scale, brand portfolio breadth, and multi-site operating model — useful as a US TAM benchmark.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@virtushealth4076
• LinkedInlinkedin.com/company/virtus-health

Revenue estimate

Valuation estimate

Number of profiles

Profiles17 records

Subsidiaries13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Virtus Health